NCT05986851 2026-03-31Azeliragon in MGMT Unmethylated GlioblastomaCantex PharmaceuticalsPhase 2 Active not recruiting30 enrolled
NCT05635734 2026-02-05Azeliragon and Chemoradiotherapy in Newly Diagnosed GlioblastomaCantex PharmaceuticalsPhase 1/2 Active not recruiting18 enrolled